Mitsubishi Tanabe Pharma Corporation

11/15/2018 | Press release | Distributed by Public on 11/15/2018 00:03

Mitsubishi Tanabe Pharma to present New data on Investigational Oral Suspension of Edaravone for ALS at 29th International Symposium on ALS/MND